Quarterly Consolidated Balance Sheet

JCR Pharmaceuticals Co.,Ltd. - Filing #7350553

Concept As at
2023-12-31
As at
2023-03-31
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
18,301,000,000 JPY
13,278,000,000 JPY
Merchandise and finished goods
1,669,000,000 JPY
1,098,000,000 JPY
Work in process
6,495,000,000 JPY
5,717,000,000 JPY
Raw materials and supplies
12,666,000,000 JPY
11,699,000,000 JPY
Other
2,055,000,000 JPY
4,870,000,000 JPY
Current assets
57,468,000,000 JPY
47,802,000,000 JPY
Non-current assets
Property, plant and equipment
30,657,000,000 JPY
32,681,000,000 JPY
Property, plant and equipment
Buildings and structures
Buildings and structures, net
14,387,000,000 JPY
7,128,000,000 JPY
Land
10,587,000,000 JPY
10,379,000,000 JPY
Construction in progress
121,000,000 JPY
13,008,000,000 JPY
Other
Other, net
5,561,000,000 JPY
2,165,000,000 JPY
Intangible assets
Other
1,381,000,000 JPY
1,217,000,000 JPY
Intangible assets
3,609,000,000 JPY
3,652,000,000 JPY
Investments and other assets
11,038,000,000 JPY
10,800,000,000 JPY
Investments and other assets
Investment securities
9,251,000,000 JPY
8,867,000,000 JPY
Other
1,791,000,000 JPY
1,938,000,000 JPY
Allowance for doubtful accounts
-4,000,000 JPY
-4,000,000 JPY
Non-current assets
45,304,000,000 JPY
47,135,000,000 JPY
Assets
102,773,000,000 JPY
94,937,000,000 JPY
Liabilities
Current liabilities
Short-term borrowings
9,700,000,000 JPY
16,800,000,000 JPY
Income taxes payable
1,950,000,000 JPY
33,000,000 JPY
Other
6,091,000,000 JPY
3,779,000,000 JPY
Current liabilities
31,914,000,000 JPY
35,762,000,000 JPY
Non-current liabilities
Long-term borrowings
13,600,000,000 JPY
5,500,000,000 JPY
Retirement benefit liability
980,000,000 JPY
924,000,000 JPY
Other
248,000,000 JPY
241,000,000 JPY
Non-current liabilities
14,910,000,000 JPY
6,761,000,000 JPY
Liabilities
46,824,000,000 JPY
42,523,000,000 JPY
Net assets
Shareholders' equity
Share capital
9,061,000,000 JPY
9,061,000,000 JPY
Capital surplus
10,384,000,000 JPY
10,384,000,000 JPY
Retained earnings
36,933,000,000 JPY
34,273,000,000 JPY
Treasury shares
-2,964,000,000 JPY
-2,978,000,000 JPY
Shareholders' equity
53,414,000,000 JPY
50,740,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
653,000,000 JPY
555,000,000 JPY
Deferred gains or losses on hedges
0 JPY
JPY
Foreign currency translation adjustment
794,000,000 JPY
146,000,000 JPY
Remeasurements of defined benefit plans
-21,000,000 JPY
-20,000,000 JPY
Valuation and translation adjustments
1,426,000,000 JPY
681,000,000 JPY
Share acquisition rights
812,000,000 JPY
740,000,000 JPY
Non-controlling interests
294,000,000 JPY
251,000,000 JPY
Net assets
55,948,000,000 JPY
52,413,000,000 JPY
Liabilities and net assets
102,773,000,000 JPY
94,937,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.